Cook's Zenith TX2 Graft With Pro-Form Approved for TEVAR


July 27, 2009—Cook Medical (Bloomington, IN) announced that the US Food and Drug Administration has approved the Zenith TX2 thoracic aortic aneurysm endovascular graft with Pro-Form, which was engineered especially for procedures in which endografts must be positioned in tight aortic arches that are difficult to seal properly. Compared to the company's original TX2 device, the Zenith TX2 graft with Pro-Form has an improved delivery system that provides more controlled deployment. The device helps establish proximal conformity of the device to the aortic wall control during endograft deployment in thoracic endovascular repair, the company stated.

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.